Drug profile · INN
nintedanib ethanesulfonate
OFEV INITIAL APPROVAL
- Patents linked
- 0
- News articles
- 0
Quick answer
nintedanib ethanesulfonate (OFEV INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN nintedanib ethanesulfonate
Brand OFEV INITIAL APPROVAL
Frequently asked questions
What is nintedanib ethanesulfonate?
nintedanib ethanesulfonate (OFEV INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for nintedanib ethanesulfonate?
OFEV INITIAL APPROVAL is a marketed brand name for nintedanib ethanesulfonate. Check FDA Drugs@FDA for the current US label holder and prescribing information.